SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-20-000230
Filing Date
2020-04-28
Accepted
2020-04-28 16:07:27
Documents
6
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 VERTEX PHARMACEUTICALS INC - DEFA14A lvrtx2020_defa14a.htm DEFA14A 14909
2 GRAPHIC lvrtx_notice1.jpg GRAPHIC 383707
3 GRAPHIC lvrtx_notice2.jpg GRAPHIC 392437
4 GRAPHIC lvrtxx1x1.jpg GRAPHIC 1312
5 GRAPHIC lvrtxx1x2.jpg GRAPHIC 1021
6 GRAPHIC lvrtxx1x3.jpg GRAPHIC 7743
  Complete submission text file 0001308179-20-000230.txt   1099367
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19319 | Film No.: 20825025
SIC: 2834 Pharmaceutical Preparations